SMS Pharmaceuticals (SMSPHARMA) — Announcement

📢 Key Event
SMS Pharmaceuticals launched investor presentation for Q1FY27 with financial updates and growth roadmap

🔄 What Changed
Revenue grew 6% YoY to ₹207 crore; PAT increased 8% YoY to ₹41 crore; EBITDA margin held at 20%

🔮 What's Next
Targeting 1.75 average net asset turnover over next 2-3 years; ₹280 crore capex to complete by FY27

💡 Investor Takeaway
Shareholders see disciplined growth in high-value APIs with margin protection through backward integration and regulated market expansion.

SMS Pharmaceuticals Limited presented its Q1FY27 investor deck highlighting 6% YoY revenue growth to ₹207 crore, sustained 20% EBITDA margin, and 8% PAT increase to ₹41 crore. The presentation emphasized progress on its ₹280 crore capex program, new peptide R&D investments, and 4 DMF/CEP filings toward a FY27 target of 10. Gross margin remained above 45% despite market pressures, supported by high-value product mix and backward integration. The company reaffirmed its focus on asset utilization and margin expansion through strategic capacity additions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SMSPHARMA ✨ Ask AI About This

About SMS Pharmaceuticals Limited (SMSPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹3,493.69 Cr P/E: 33.2 ROE: 14.3% ROCE: 15.2% Div Yield: 0.11%

View full SMSPHARMA stock details →

📡 Get AI alerts when SMSPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SMSPHARMA — Free

💡 Ask AI about this filing

"What is SMSPHARMA's target net asset turnover ratio by FY27?" "How many new DMF/CEP filings are planned in H2FY27?" "What is the expected return on the ₹280 crore capex program?"

Ask AI Free →

📊 More SMSPHARMA filings

See all SMSPHARMA filings →

🔥 Also filed on 1 August 2026

PNCINFRA PNC Infratech Limited Announcement LATENTVIEW Latent View Analytics Limited Financial Results NIITLTD NIIT Limited Announcement RVNL Rail Vikas Nigam Limited Annual Report RVNL Rail Vikas Nigam Limited Annual Report BILVYAPAR BIL VYAPAR LIMITED Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SMSPHARMA files new disclosures

Track SMSPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SMSPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd